Myogen News
Most Popular Myogen Story
Gilead dumps disappointing late-stage blood pressure drug
Gilead Sciences has decided to dump the experimental blood pressure drug darusentan after it flunked a late-stage study. Researchers had hoped to see the same kind of efficacy reported from an Read more...
Latest Headlines
- December 15, 2009
- August 16, 2007
- November 9, 2006
- October 11, 2006
- October 1, 2006
- August 10, 2006
- June 15, 2006
- March 26, 2006
- March 15, 2006
- March 6, 2006
- March 2, 2006
- December 11, 2005
- September 15, 2005
- August 18, 2005
- August 17, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
